Home
John Mendlein, Director: Fate Therapeutics FATE Buy · Filed 23/01/13
Trade details
- Type
- Insider buy
- Amount
- $499,232.16
- Shares · price
- 88,048 sh · $5.67 a share
- Held after
- 246,139 sh
- Person
- John MendleinDirector
- Trade date
- 23/01/11
- Filed
- 23/01/13
- Days to filing
- 2 days
Holdings up 55.7%
- Insiders buying this week
- 1 insiders
- Holding change
- +55.7%
Fate Therapeutics trades, last 26 weeks
What else happened in Fate Therapeutics around then
Filed or reported within 30 days of the trade day · 22/12/12~23/02/10John Mendlein's recent trades
- John Mendlein
Planned saleFate Therapeutics
Planned saleFate Therapeutics
FATE
$38.9K
38,428 sh
$38.9K
Filed 25/12/29
Traded 25/12/24
- John Mendlein
BuyFate Therapeutics
BuyFate Therapeutics
FATE
$198.9K
36,631 sh
$198.9K
Filed 23/01/13
Traded 23/01/13